| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680448 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018 | 8 Pages |
Abstract
Removal of FP MCI diagnoses unmasked beneficial effects of donepezil, despite a 30% reduction in sample size. MCI subject selection based on actuarial methods with comprehensive neuropsychological test data can result in more efficient clinical trials and improved ability to detect treatment effects.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Emily C. Edmonds, M. Colin Ard, Steven D. Edland, Douglas R. Galasko, David P. Salmon, Mark W. Bondi,